CSOP Hang Seng Biotech ETF(03174.HK)Rises 0.80% intraday, Net Asset Value at HKD 3.518

NewTimeSpace News: As of 13:12 on April 28, CSOP Hang Seng Biotech ETF(03174.HK) rose 0.80% to HKD 3.548, hitting an intraday high of HKD 3.632. Turnover was approximately HKD 25.867 million, with a volume of 720,400 shares and a turnover rate of 0.28%. The premium rate stood at 0.07%, with a net asset value of HKD 3.518, an asset size of approximately HKD 891 million, and a total issuance of 253 million shares.

CSOP Hang Seng Biotech ETF(03174.HK) tracks the Hang Seng Bio-Tech Index. The ETF aims to reflect the overall performance of biotech companies listed in Hong Kong. Its constituent stocks focus on areas such as innovative drug R&D, biotechnology, medical devices, and healthcare services, covering growth-stage companies with high R&D investment in the mainland China and Hong Kong markets.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.